Patents Examined by Marjorie A. Moran
-
Patent number: 7142988Abstract: The present invention discloses a novel method and an information system for allowing a non-random selection of a genotype of a plant cultivar that yields a selected plant product with desired processing features. The method involves determining structural and functional variables of the selected plant product, genetic variables responsible for said structural and functional variables and processing variables of the selected plant, and correlating the structural and functional variables to the genetic variables and to the processing variables so as to make a non-random selection of the genotype of the plant cultivar that yields the plant product with desired processing features.Type: GrantFiled: March 9, 2000Date of Patent: November 28, 2006Assignee: Monsanto CompanyInventor: Peter C. Johnson
-
Patent number: 7138516Abstract: A method for preparing probes, as well as several probes for use in qualitative or quantitative hybridization assays are disclosed. The method comprises constructing an oligonucleotide that is sufficiently complementary to hybridize to a region of rRNA selected to be unique to a non-viral organism or group of non-viral organisms sought to be detected, said region of rRNA being selected by comparing one or more variable region rRNA sequences of said non-viral organism or group of non-viral organisms with one or more variable region rRNA sequences from one or more non-viral organisms sought to be distinguished. Hybridization assay probes for Mycobacterium avium, Mycobacterium intracellulare, the Mycobacterium tuberculosis-complex bacteria, Mycoplasma pneumoniae, Legionella, Salmonella, Chlamydia trachomatis, Campylobacter, Proteus mirabilis, Enterococcus, Enterobacter cloacae, E. coli, Pseudomonas group I, Neisseria gonorrhoeae, bacteria, and fungi also are disclosed.Type: GrantFiled: May 30, 1995Date of Patent: November 21, 2006Assignee: Gen-Probe IncorporatedInventors: James John Hogan, Richard Dana Smith, Jo Ann Kop, Sherrol Hoffa McDonough
-
Patent number: 7133814Abstract: A system for modeling thrombopoietic lineage in an individual is presented. The system comprises a thrombopoiesis system model including a process progression model, for cells involved in thrombopoiesis, said progression model including multiplication and differentiation. It further comprises a system model modifier, wherein said thrombopoiesis system model is modified by the system model modifier based on parameters specific to the individual. In addition to modifying an individual's thrombopoietic process, the system can be modified to portray different pathological scenarios as well as different scenarios of response to treatment.Type: GrantFiled: April 6, 2001Date of Patent: November 7, 2006Assignee: Optimata Ltd.Inventors: Zvia Agur, Sarel Fleishmann, Kirill Skomorovski, Moshe Vardi
-
Patent number: 7130747Abstract: A process is provided for the high throughput screening of binding of ligands to macromolecules using high resolution powder diffraction data including producing a first sample slurry of a selected polycrystalline macromolecule material and a solvent, producing a second sample slurry of a selected polycrystalline macromolecule material, one or more ligands and the solvent, obtaining a high resolution powder diffraction pattern on each of said first sample slurry and the second sample slurry, and, comparing the high resolution powder diffraction pattern of the first sample slurry and the high resolution powder diffraction pattern of the second sample slurry whereby a difference in the high resolution powder diffraction patterns of the first sample slurry and the second sample slurry provides a positive indication for the formation of a complex between the selected polycrystalline macromolecule material and at least one of the one or more ligands.Type: GrantFiled: May 31, 2001Date of Patent: October 31, 2006Assignee: Los Alamos National Security, LLCInventors: Robert B. Von Dreele, Kevin D'Amico
-
Patent number: 7129338Abstract: Human cDNA encoding a secretory or membrane protein useful as a candidate for developing medicine or as a target molecule for developing medicine. The expression level of the polynucleotide of the present invention increased in NT2 cells after retinoic acid-treatment. Accordingly, this cDNA is associated neurological disease.Type: GrantFiled: November 27, 2002Date of Patent: October 31, 2006Assignee: Research Association for BiotechnologyInventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Yuri Kawai, Tomoyasu Sugiyama, Koji Hayashi
-
Patent number: 7127379Abstract: The present invention relates to methods for achieving an optimal function of a biochemical reaction network. The methods can be performed in silico using a reconstruction of a biochemical reaction network of a cell and iterative optimization procedures. The methods can further include laboratory culturing steps to confirm and possibly expand the determinations made using the in silico methods, and to produce a cultured cell, or population of cells, with optimal functions. The current invention includes computer systems and computer products including computer-readable program code for performing the in silico steps of the invention.Type: GrantFiled: August 27, 2001Date of Patent: October 24, 2006Assignee: The Regents of the University of CaliforniaInventors: Bernhard O. Palsson, Jeremy S. Edwards
-
Patent number: 7127357Abstract: A WW domain crystal structure of Pin1 is provided. In addition, methods of using the crystal structure and atomic coordinates for the development of WW domain binding agents is also provided. Also provided are computer programs on computer readable medium for use in developing WW domain binding agents.Type: GrantFiled: December 8, 2000Date of Patent: October 24, 2006Assignee: The Salk Institute for Biological StudiesInventors: Joseph P. Noel, Mark A. Verdecia
-
Patent number: 7117098Abstract: The present invention provides systems, methods, and screens for an optical system analysis of cells to rapidly determine the distribution, environment, or activity of fluorescently labeled reporter molecules in cells for the purpose of screening large numbers of compounds for those that specifically affect particular biological functions. The invention involves providing cells containing fluorescent reporter molecules in an array of locations and scanning numerous cells in each location with a high magnification fluorescence optical system, converting the optical information into digital data, and utilizing the digital data to determine the distribution, environment or activity of the fluorescently labeled reporter molecules in the cells. The array of locations may be an industry standard 96 well or 384 well microtiter plate or a microplate which is a microplate having a cells in a micropaterned array of locations.Type: GrantFiled: November 27, 2000Date of Patent: October 3, 2006Assignee: Cellomics, Inc.Inventors: R. Terry Dunlay, D. Lansing Taylor, Albert H. Gough, Kenneth A. Giuliano
-
Patent number: 7115364Abstract: The invention provides chips of immobilized probes, and methods employing the chips, for comparing a reference polynucleotide sequence of known sequence with a target sequence showing substantial similarity with the reference sequence, but differing in the presence of e.g., mutations.Type: GrantFiled: August 2, 1995Date of Patent: October 3, 2006Assignee: Affymetrix, Inc.Inventors: Mark Chee, Maureen T. Cronin, Stephen P. A. Fodor, Thomas R. Gingeras, Xiaohua C. Huang, Earl A. Hubbell, Robert J. Lipshutz, Peter E. Lobban, Charles Garrett Miyada, Macdonald S. Morris, Nila Shah, Edward L. Sheldon
-
Patent number: 7115712Abstract: New cytokine polypeptides, and nucleic acids encoding them, are provided. Compositions including these polypeptides and nucleic acids, recombinant cells comprising said polypeptides and nucleic acids, methods of making the polypeptides and nucleic acid, antibodies to the polypeptides, and methods of using the polypeptides and nucleic acids are provided. Integrated systems comprising the sequences of the nucleic acids or polypeptides are also provided.Type: GrantFiled: November 28, 2000Date of Patent: October 3, 2006Assignee: Maxygen, Inc.Inventors: Steven R. Leong, Juha Punnonen
-
Patent number: 7112668Abstract: Disclosed are novel polypeptides and nucleic acids encoding same. Also disclosed are vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same.Type: GrantFiled: January 22, 2002Date of Patent: September 26, 2006Assignee: CuraGen CorporationInventors: Luca Rastelli, Xiaojia (Sasha) Guo
-
Patent number: 7092825Abstract: A method of protein engineering is provided wherein a searchable computer database is created comprising entries in the form of descriptions of a location and orientation in 3D space of side chains of the constituent amino acid residues of a framework protein. A query is created which corresponds to a description of a location and orientation in 3D space of respective side chains of amino acid residues of a sample protein. The location and orientation in 3D space of constituent side-chains is preferably described as a C?–C? vector. The query is used to search the database and thereby identify a hit which corresponds to a framework protein having structural similarity with said sample protein. Framework protein “hits” so identified may be suitable candidates for further modification. A particular advantage of the present invention is that a modified framework protein may display one or more desired characteristics, such as a function similar to or inhibitory of the sample protein.Type: GrantFiled: October 21, 1999Date of Patent: August 15, 2006Assignee: The University of QueenslandInventors: Mark Leslie Smythe, Michael John Dooley, Peter Ronald Andrews
-
Patent number: 7090972Abstract: A method for preparing probes, as well as several probes for use in qualitative or quantitative hybridization assays are disclosed. The method comprises constructing an oligonucleotide that is sufficiently complementary to hybridize to a region of rRNA selected to be unique to a non-viral organism or group of non-viral organisms sought to be detected, said region of rRNA being selected by comparing one or more variable region rRNA sequences of said non-viral organism or group of non-viral organisms with one or more variable region rRNA sequences from one or more non-viral organisms sought to be distinguished. Hybridization assay probes for Mycobacterium avium, Mycobacterium intracellulare, the Mycobacterium tuberculosis-complex bacteria, Mycoplasma pneumoniae, Legionella, Salmonella, Chlamydia trachomatis, Campylobacter, Proteus mirabilis, Enterococcus, Enterobacter cloacae, E. coli, Pseudomonas group I, Neisseria gonorrhoeae, bacteria, and fungi also are disclosed.Type: GrantFiled: May 30, 1995Date of Patent: August 15, 2006Assignee: Gen-Probe IncorporatedInventors: James John Hogan, Richard Dana Smith, JoAnn Kop, Sherrol Hoffa McDonough
-
Patent number: 7087742Abstract: A method for preparing probes, as well as several probes for use in qualitative or quantitative hybridization assays are disclosed. The method comprises constructing an oligonucleotide that is sufficiently complementary to hybridize to a region of rRNA selected to be unique to a non-viral organism or group of non-viral organisms sought to be detected, said region of rRNA being selected by comparing one or more variable region rRNA sequences of said non-viral organism or group of non-viral organisms with one or more variable region rRNA sequences from one or more non-viral organisms sought to be distinguished. Hybridization assay probes for Mycobacterium avium, Mycobacterium intracellulare, the Mycobacterium tuberculosis-complex bacteria, Mycoplasma pneumoniae, Legionella, Salmonella, Chlamydia trachomatis, Campylobacter, Proteus mirabilis, Enterococcus, Enterobacter cloacae, E. coli, Pseudomonas group I, Neisseria gonorrhoeae, bacteria, and fungi also are disclosed.Type: GrantFiled: May 31, 1995Date of Patent: August 8, 2006Assignee: Gen-Probe IncorporatedInventors: James John Hogan, Richard Dana Smith, JoAnn Kop, Sherrol Hoffa McDonough
-
Patent number: 7074901Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.Type: GrantFiled: August 6, 2001Date of Patent: July 11, 2006Assignee: Serono Genetics Institute S.A.Inventors: Stephane Bejanin, Hiroaki Tanaka
-
Patent number: 7067500Abstract: The present invention is directed to methods of antimicrobial therapy for a patient infected with, or suspected of being infected with a microorganism that has mycolic acid structures in its outer membrane, said method comprising coadministering a betaine-like detergent and an antibiotic to said patient in an amount and for a length of time sufficient to kill said microorganism.Type: GrantFiled: April 19, 2002Date of Patent: June 27, 2006Assignee: Integrated Research Technology, LLCInventor: Charles G. Thornton
-
Patent number: 7065453Abstract: A high-throughput molecular docking facility is presented for screening combinatorial libraries to identify binding ligands and ultimately pharmaceutical compounds. The facility employs a pre-docking conformational search to generate multiple solution conformations of a ligand. The molecular docking facility includes: generating a binding site image of the protein, the binding site image having multiple hot spots; matching hot spots of the binding site image to atoms in at least one solution conformation of the multiple solution conformations of the ligand to obtain at least one ligand position relative to the protein in a ligand-protein complex formation; and optimizing the at least one ligand position while allowing translation, orientation and rotatable bonds of the ligand to vary, and while holding the protein fixed.Type: GrantFiled: June 15, 2000Date of Patent: June 20, 2006Assignee: Accelrys Software, Inc.Inventors: David J. Diller, Kenneth M. Merz, Jr.
-
Patent number: 7065452Abstract: The present invention relates to crystallized molecules and molecular complexes which comprise the active site binding pocket or the FKBP12/FK506 binding pocket of calcineurin or close structural homologues to either binding pocket. This invention also relates to a data storage material encoded with the corresponding structure coordinates of those crystallized molecules or molecular complexes. Such data storage material is capable of displaying such molecules and molecular complexes as a graphical three-dimensional representation on a computer screen. In addition, this invention relates to methods of using the structure coordinates of those molecules or molecular complexes to solve the structure of homologous proteins. This invention also relates to methods of using the structure coordinates to screen and design compounds that bind to calcineurin or homologues thereof.Type: GrantFiled: November 1, 1999Date of Patent: June 20, 2006Assignee: Vertex Pharmaceuticals IncorporatedInventors: David M. Armistead, Matthew James Fitzgibbon, Mark Andrew Fleming, James P. Griffith, Eunice E. Kim, Joseph L. Kim, Michael D. Sintchak, John Allan Thomson, Keith P. Wilson
-
Patent number: 7060224Abstract: Methods and apparatus are provided for the fabrication of microscale, including micron and sub-micron scale, including nanoscale, devices. Electronic transport of movable component devices is utilized through a fluidic medium to effect transport to a desired target location on a substrate or motherboard. Forces include electrophoretic force, electroosmotic force, electrostatic force and/or dielectrophoretic force. In the preferred embodiment, free field electroosmotic forces are utilized either alone, or in conjunction with, other forces. These forces may be used singly or in combination, as well as in conjunction with yet other forces, such as fluidic forces, mechanical forces or thermal convective forces. Transport may be effected through the use of driving electrodes so as to transport the component device to yet other connection electrodes. In certain embodiments, the component devices may be attached to the target device using a solder reflow step.Type: GrantFiled: January 6, 2003Date of Patent: June 13, 2006Assignee: Nanogen, Inc.Inventors: Carl F. Edman, Michael J. Heller, Rachel Formosa, Christian Gurtner
-
Patent number: 7062384Abstract: Provided are methods of classifying biological samples based on high dimensional data obtained from the samples. The methods are especially useful for prediction of a class to which the sample belongs under circumstances in which the data are statistically under-determined. The advent of microarray technologies which provide the ability to measure en masse many different variables (such as gene expression) at once has resulted in the generation of high dimensional data sets, the analysis of which benefits from the methods of the present invention. High dimensional data is data in which the number of variables, p, exceeds the number of independent observations (e.g. samples), N, made. The invention relies on a dimension reduction step followed by a logistic determination step. The methods of the invention are applicable for binary (i.e. univariate) classification and multi-class (i.e. multivariate) classifications.Type: GrantFiled: September 19, 2001Date of Patent: June 13, 2006Assignee: The Regents of the University of CaliforniaInventors: David M. Rocke, Danh V. Nguyen